Perioperative change of circulating tumor cells in cytoreductive radical prostatectomy for oligometastatic hormone-sensitive prostate cancer: the preliminary safety evidence from long-term oncologic outcomes-Reference-Cited by-同舟云学术

Perioperative change of circulating tumor cells in cytoreductive radical prostatectomy for oligometastatic hormone-sensitive prostate cancer: the preliminary safety evidence from long-term oncologic outcomes

Published:2023-05-09 Issue:7 Volume:55 Page:1709-1717
ISSN:1573-2584
Container-title:International Urology and Nephrology
language:en
Short-container-title:Int Urol Nephrol

Author:

Maskey Niraj,Mao Shiyu,Yang Guanjie,Guo Yadong,Kadier Aimaitiaji,Yuan Jing,Xie Jun,Guo Changcheng,Yang Bin,Yao Xudong

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Urology,Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s11255-023-03622-0.pdf

Reference31 articles.

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386

2. Arya M, Bott SR, Shergill IS, Ahmed HU, Williamson M et al (2006) The metastatic cascade in prostate cancer. Surg Oncol 15:117–128

3. Heidenreich A, Pfister D, Porres D (2015) Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study. J Urol 193:832–838

4. Eschwege P, Moutereau S, Droupy S, Douard R, Gala JL et al (2009) Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study. Br J Cancer 100:608–610

5. Kauffman EC, Lee MJ, Alarcon SV, Lee S, Hoang AN et al (2016) Lack of impact of robotic assisted laparoscopic radical prostatectomy on intraoperative levels of prostate cancer circulating tumor cells. J Urol 195:1136–1142